What to expect when you take Phenazopyridine hcl and Amrix?

Do you take Phenazopyridine hcl and Amrix? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials). If you find eHealthMe useful, please help us to spread the words below or leave us a testimonial.



On Jan, 11, 2019

11,206 reports have been studied.


Females aged 50 to 59 :

8,325 related reports were analyzed:

Most common symptoms:

Back pain
  • 9.38% for females aged 50 (±5) who take Phenazopyridine hcl
  • 6.0% for females aged 50 (±5) who take Amrix
Broken bone
  • 7.62% for females aged 50 (±5) who take Phenazopyridine hcl
Chest pain
  • 8.8% for females aged 50 (±5) who take Phenazopyridine hcl
  • 5.34% for females aged 50 (±5) who take Amrix
Dehydration
  • 6.16% for females aged 50 (±5) who take Phenazopyridine hcl
Depression
  • 9.38% for females aged 50 (±5) who take Phenazopyridine hcl
  • 5.94% for females aged 50 (±5) who take Amrix
Diarrhea
  • 10.85% for females aged 50 (±5) who take Phenazopyridine hcl
  • 5.55% for females aged 50 (±5) who take Amrix
Dizziness
  • 9.09% for females aged 50 (±5) who take Phenazopyridine hcl
  • 6.28% for females aged 50 (±5) who take Amrix
Drug ineffective
  • 6.02% for females aged 50 (±5) who take Amrix
Dyspnea
  • 11.14% for females aged 50 (±5) who take Phenazopyridine hcl
  • 5.72% for females aged 50 (±5) who take Amrix
Fainting
  • 5.28% for females aged 50 (±5) who take Phenazopyridine hcl
Fall
  • 8.5% for females aged 50 (±5) who take Phenazopyridine hcl
  • 5.89% for females aged 50 (±5) who take Amrix
Fatigue
  • 10.26% for females aged 50 (±5) who take Phenazopyridine hcl
  • 9.18% for females aged 50 (±5) who take Amrix
Febrile neutropenia
  • 5.57% for females aged 50 (±5) who take Phenazopyridine hcl
Gait disturbance
  • 5.57% for females aged 50 (±5) who take Phenazopyridine hcl
Headache
  • 9.68% for females aged 50 (±5) who take Phenazopyridine hcl
  • 7.84% for females aged 50 (±5) who take Amrix
High blood pressure
  • 6.11% for females aged 50 (±5) who take Amrix
Hypoaesthesia
  • 7.04% for females aged 50 (±5) who take Phenazopyridine hcl
Intervertebral disc protrusion
  • 7.62% for females aged 50 (±5) who take Phenazopyridine hcl
Joint pain
  • 6.39% for females aged 50 (±5) who take Amrix
  • 5.28% for females aged 50 (±5) who take Phenazopyridine hcl
Malaise
  • 5.28% for females aged 50 (±5) who take Phenazopyridine hcl
Nausea
  • 14.96% for females aged 50 (±5) who take Phenazopyridine hcl
  • 9.47% for females aged 50 (±5) who take Amrix
Nausea and vomiting
  • 11.14% for females aged 50 (±5) who take Phenazopyridine hcl
  • 5.02% for females aged 50 (±5) who take Amrix
Pain
  • 11.16% for females aged 50 (±5) who take Amrix
  • 10.56% for females aged 50 (±5) who take Phenazopyridine hcl
Pain in extremity
  • 5.57% for females aged 50 (±5) who take Phenazopyridine hcl
Pain in jaw
  • 5.57% for females aged 50 (±5) who take Phenazopyridine hcl
Stress and anxiety
  • 8.5% for females aged 50 (±5) who take Phenazopyridine hcl
  • 6.66% for females aged 50 (±5) who take Amrix
Stroke
  • 5.57% for females aged 50 (±5) who take Phenazopyridine hcl
Urinary tract infection
  • 15.54% for females aged 50 (±5) who take Phenazopyridine hcl
Vision blurred
  • 5.28% for females aged 50 (±5) who take Phenazopyridine hcl
Weakness
  • 10.85% for females aged 50 (±5) who take Phenazopyridine hcl
  • 6.0% for females aged 50 (±5) who take Amrix
Weight decreased
  • 8.21% for females aged 50 (±5) who take Phenazopyridine hcl

Most common co-existing conditions:

Depression
  • 10.91% for females aged 50 (±5) who take Amrix
  • 8.8% for females aged 50 (±5) who take Phenazopyridine hcl
Fibromyalgia
  • 9.08% for females aged 50 (±5) who take Amrix
Gastroesophageal reflux disease
  • 6.21% for females aged 50 (±5) who take Amrix
High blood cholesterol
  • 6.43% for females aged 50 (±5) who take Amrix
High blood pressure
  • 9.38% for females aged 50 (±5) who take Phenazopyridine hcl
  • 9.26% for females aged 50 (±5) who take Amrix
Multiple sclerosis
  • 8.5% for females aged 50 (±5) who take Phenazopyridine hcl
  • 5.72% for females aged 50 (±5) who take Amrix
Muscle spasms
  • 8.62% for females aged 50 (±5) who take Amrix
Pain
  • 17.01% for females aged 50 (±5) who take Phenazopyridine hcl
  • 16.46% for females aged 50 (±5) who take Amrix
Restless leg syndrome
  • 5.57% for females aged 50 (±5) who take Phenazopyridine hcl
Rheumatoid arthritis
  • 11.8% for females aged 50 (±5) who take Amrix
Stress and anxiety
  • 7.38% for females aged 50 (±5) who take Amrix
  • 5.87% for females aged 50 (±5) who take Phenazopyridine hcl
back to top

Males aged 50 to 59 :

2,881 related reports were analyzed:

Most common symptoms:

Abdominal pain
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Acute myocardial infarction
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Albumin globulin ratio increased
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Angina unstable
  • 10.53% for males aged 50 (±5) who take Phenazopyridine hcl
Appetite - decreased
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Atherosclerosis
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Back pain
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
  • 5.71% for males aged 50 (±5) who take Amrix
Blood glucose increased
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Blood urine present
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Bursitis
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Chills
  • 7.37% for males aged 50 (±5) who take Phenazopyridine hcl
Chronic obstructive airways disease
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Colitis
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Confusion
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Confusional state
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Cuts and puncture wounds
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Depression
  • 10.53% for males aged 50 (±5) who take Phenazopyridine hcl
  • 6.53% for males aged 50 (±5) who take Amrix
Dizziness
  • 10.53% for males aged 50 (±5) who take Phenazopyridine hcl
Drug ineffective
  • 9.47% for males aged 50 (±5) who take Phenazopyridine hcl
  • 6.17% for males aged 50 (±5) who take Amrix
Dyspnea
  • 10.53% for males aged 50 (±5) who take Phenazopyridine hcl
  • 5.53% for males aged 50 (±5) who take Amrix
Emotional distress
  • 9.47% for males aged 50 (±5) who take Phenazopyridine hcl
Fall
  • 7.37% for males aged 50 (±5) who take Phenazopyridine hcl
Fatigue
  • 12.63% for males aged 50 (±5) who take Phenazopyridine hcl
  • 6.89% for males aged 50 (±5) who take Amrix
Fear, focus
  • 7.37% for males aged 50 (±5) who take Phenazopyridine hcl
Fever
  • 11.58% for males aged 50 (±5) who take Phenazopyridine hcl
Gait disturbance
  • 8.42% for males aged 50 (±5) who take Phenazopyridine hcl
Head injury
  • 11.58% for males aged 50 (±5) who take Phenazopyridine hcl
Headache
  • 10.53% for males aged 50 (±5) who take Phenazopyridine hcl
  • 5.67% for males aged 50 (±5) who take Amrix
Heart attack
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Hiatal hernia
  • 7.37% for males aged 50 (±5) who take Phenazopyridine hcl
Injury
  • 8.42% for males aged 50 (±5) who take Phenazopyridine hcl
Insomnia
  • 7.37% for males aged 50 (±5) who take Phenazopyridine hcl
Joint pain
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Kidney stones
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Libido decreased
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Loss of consciousness
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Malaise
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Movement disorder
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Muscle aches
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Muscle spasms
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Nausea
  • 10.53% for males aged 50 (±5) who take Phenazopyridine hcl
  • 5.89% for males aged 50 (±5) who take Amrix
Neck mass
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Neurodegenerative disorder
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Pain
  • 11.58% for males aged 50 (±5) who take Phenazopyridine hcl
  • 8.51% for males aged 50 (±5) who take Amrix
Pain in extremity
  • 7.37% for males aged 50 (±5) who take Phenazopyridine hcl
Parkinson's disease
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Pharyngeal oedema
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Pleural effusion
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Rhabdomyolysis
  • 8.42% for males aged 50 (±5) who take Phenazopyridine hcl
Skin blushing/flushing
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Speech impairment (adult)
  • 8.42% for males aged 50 (±5) who take Phenazopyridine hcl
Stress and anxiety
  • 11.58% for males aged 50 (±5) who take Phenazopyridine hcl
  • 6.5% for males aged 50 (±5) who take Amrix
Suicidal ideation
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Thrombocytopenia
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Transient ischaemic attack
  • 9.47% for males aged 50 (±5) who take Phenazopyridine hcl
Urinary tract infection
  • 7.37% for males aged 50 (±5) who take Phenazopyridine hcl
Urination - excessive at night
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Urination - painful
  • 7.37% for males aged 50 (±5) who take Phenazopyridine hcl
Vision blurred
  • 10.53% for males aged 50 (±5) who take Phenazopyridine hcl
Weakness
  • 7.37% for males aged 50 (±5) who take Phenazopyridine hcl
  • 5.38% for males aged 50 (±5) who take Amrix
Weight decreased
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl

Most common co-existing conditions:

Anaemia
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Anticoagulant therapy
  • 9.47% for males aged 50 (±5) who take Phenazopyridine hcl
Bladder disorder
  • 9.47% for males aged 50 (±5) who take Phenazopyridine hcl
Constipation
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Cystitis interstitial
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Depression
  • 7.21% for males aged 50 (±5) who take Amrix
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Enlarged prostate
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Gait disturbance
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Gastroesophageal reflux disease
  • 9.47% for males aged 50 (±5) who take Phenazopyridine hcl
High blood cholesterol
  • 13.68% for males aged 50 (±5) who take Phenazopyridine hcl
  • 8.51% for males aged 50 (±5) who take Amrix
High blood pressure
  • 12.63% for males aged 50 (±5) who take Phenazopyridine hcl
  • 10.48% for males aged 50 (±5) who take Amrix
Hiv infection
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Itching
  • 8.42% for males aged 50 (±5) who take Phenazopyridine hcl
Muscle spasms
  • 7.68% for males aged 50 (±5) who take Amrix
Muscle spasticity
  • 7.37% for males aged 50 (±5) who take Phenazopyridine hcl
Musculoskeletal stiffness
  • 6.32% for males aged 50 (±5) who take Phenazopyridine hcl
Nasopharyngitis
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
Pain
  • 16.69% for males aged 50 (±5) who take Amrix
  • 13.68% for males aged 50 (±5) who take Phenazopyridine hcl
Stress and anxiety
  • 5.42% for males aged 50 (±5) who take Amrix
Type 2 diabetes
  • 5.26% for males aged 50 (±5) who take Phenazopyridine hcl
back to top

Do you take Phenazopyridine hcl and Amrix:

  • To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here

Related studies

Phenazopyridine hcl

Phenazopyridine hcl has active ingredients of phenazopyridine hydrochloride. It is often used in urinary tract infection. (latest outcomes from Phenazopyridine hcl 1,343 users)

Amrix

Amrix has active ingredients of cyclobenzaprine hydrochloride. It is often used in back pain. (latest outcomes from Amrix 921 users)

General study

Recent updates

Recent general studies
Recent personal studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!